Come up with a name for your new list and we'll add to it:
Regennera raised a round of funding on June 13, 2017. Investors include
Phase 1 Ventures.
Regennera is developing a novel pre-vascularized, load-bearing synthetic bone graft with IP from Rutgers, The State University of New Jersey. This all-in-one fracture repair device is capable of devel…